Xeloda (capecitabine)

Information on this site is not intended as medical advice and should not be used as a substitute for consulting with qualified doctor.

Xeloda is a highly effective targeted oral chemotherapy offering patients a survival advantage when taken on its own or in combination with other anticancer drugs. Xeloda is converted to the active cancer-killing agent 5-FU (5-fluorouracil) directly inside the cancer cells, thus reducing damage to healthy cells. Xeloda tablets can be taken by patients in their own home, reducing the number of hospital visits.1

 

In Bangladesh Xeloda is approved for the following indications.2

  • Breast cancer
  • Colon, colorectal cancer
  • Oesophagogastric cancer

 

For more disease and medicine related queries you may discuss with your physician.

 

In Bangladesh Xeloda is available as

Film-coated tablets 500 mg

 

 

References

1. Global Website: Investors. Xeloda in combination with oxaliplatin shown to be effective in early colon cancer (2009, July 20). [Internet; cited 2018, December 03]. Retrieved from https://www.roche.com/investors/updates/inv-update-2009-07-20.htm

2. Xeloda Product Information _ FE-English Ro 09-1978 _ September 2018